UBS Group
GOVX icon

UBS Group’s GeoVax Labs GOVX Stock Holding History

UBS Group’s Portfolio GOVX Stock Details GOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-39
Closed -$657 – 11375
2026
Q2 		$1.2K Sell
39
-138
-78% -$5.04K ﹤0.01% 9610
2026
Q1 		$5.86K Buy
177
+28
+19% +$1.61K ﹤0.01% 8737
2025
Q4 		$15.3K Buy
149
+52
+54% +$13.7K ﹤0.01% 7966
2025
Q3 		$27.6K Sell
97
-237
-71% -$99.5K ﹤0.01% 7949
2025
Q2 		$173K Buy
334
+182
+120% +$109K ﹤0.01% 6816
2025
Q1 		$97K Buy
152
+105
+223% +$111K ﹤0.01% 7070
2024
Q4 		$69.9K Buy
47
+45
+2,250% +$62.5K ﹤0.01% 7082
2024
Q3 		$2.75K Buy
+2
New +$4.04K ﹤0.01% 8373
2023
Q4 		– Sell
-2
Closed -$9.8K – 9532
2023
Q3 		$9.8K Buy
+2
New +$10K ﹤0.01% 7122
2023
Q2 		– Sell
-2
Closed -$11.5K – 8255
2023
Q1 		$9.7K Buy
+2
New +$13.5K ﹤0.01% 7630
2022
Q3 		– Hold
0
– -$4K – 10558
2022
Q2 		– Hold
0
– – – 9069
2022
Q1 		– Sell
-1
Closed -$16K – 10492
2021
Q4 		$16K Buy
+1
New +$35.6K ﹤0.01% 8159
2021
Q3 		– Hold
0
– – – 8198
2021
Q1 		– Hold
0
– -$7K – 9180
2020
Q4 		– Hold
0
– – – 7687

Other funds holding GOVX

StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return

UBS Group's GOVX Position: Q3 2026 in Review

UBS Group sold out of GeoVax Labs (GOVX) in Q3 2026, closing a stake of 39 shares — an estimated $657 sold.

UBS Group first reported a position in GOVX in Q4 2021 and held it in 11 quarters. The position peaked at $173K in Q2 2025. 4 funds tracked by Wall St. Rank hold GOVX as of Q3 2026.

  • UBS Group reported no remaining GeoVax Labs position as of Q3 2026 after selling out during the quarter.
  • UBS Group sold 39 GeoVax Labs shares in Q3 2026, an estimated $657.
  • UBS Group first reported a position in GeoVax Labs in Q4 2021 and held it in 11 quarters.
  • UBS Group's GeoVax Labs position peaked at $173K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held GeoVax Labs as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.